Detalhe da pesquisa
1.
Cryptococcal meningoencephalitis: time for action.
Lancet Infect Dis
; 21(9): e259-e271, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33872594
2.
Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study.
Lancet HIV
; 7(9): e620-e628, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32890497
3.
Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.
Trials
; 20(1): 48, 2019 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30642386
4.
AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study.
BMJ Open
; 9(4): e026288, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30940760
5.
AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.
Trials
; 19(1): 649, 2018 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30470259
6.
A pragmatic approach to managing antiretroviral therapy-experienced patients diagnosed with HIV-associated cryptococcal meningitis: impact of antiretroviral therapy adherence and duration.
AIDS
; 34(9): 1425-1428, 2020 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32590438